Skip to Content
VaccinesVaccines
  • Review
  • Open Access

18 November 2026

26 Pages

Multicomponent Interventions to Improve Hepatitis B Vaccination Uptake Among Double-Negative Population

,
,
,
,
,
,
,
,
…
1
NMPA Key Laboratory for Safety Evaluation of Cosmetics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China
2
Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511400, China
3
School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China
4
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511400, China

Abstract

A substantial proportion of individuals identified through hepatitis B screening are double-negative (HBsAg-negative and anti-HBs-negative) and remain fully susceptible to hepatitis B virus (HBV) infection despite the availability of an effective vaccine. PubMed, Web of Science, and CNKI were searched for literature published between January 2000 and December 2025 on barriers to HBV vaccination in double-negative populations and the interventions addressing them. Barriers operate at individual (knowledge deficits, vaccine hesitancy), service delivery (geographic inaccessibility, financial burden, disconnected screening-to-vaccination pathways), and policy (weak provider incentives, insufficient cross-sector coordination) levels. Reported interventions comprise patient-oriented strategies (reminder and recall, Health Belief Model- and Theory of Planned Behavior-based education, community engagement), provider-oriented approaches (clinical decision support, vaccination incentives, Plan-Do-Study-Act cycles), and policy-level measures (controlled temperature chain, pay-it-forward, service decentralization). Multicomponent bundles may be complementary and produce greater effects than single components; however, direct head-to-head evidence in the double-negative population is limited. Double-negative status is a convergent end-point phenotype of three immunological trajectories (never-vaccinated, vaccine non-responders, and waned immunity), and interventions should therefore be stratified accordingly. A “Screening-Education-Vaccination-Follow-up” framework is proposed, and pragmatic cluster-randomized trials with nested cost-effectiveness analyses should be prioritized.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.